Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-24-016590
Filing Date
2024-09-20
Accepted
2024-09-20 14:18:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 y920242sc13ga1.htm SC 13G/A 37897
  Complete submission text file 0001214659-24-016590.txt   39331
Mailing Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608
Business Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608 97236938448
Galmed Pharmaceuticals Ltd. (Subject) CIK: 0001595353 (see all company filings)

EIN.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88495 | Film No.: 241312940
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address YUKARIGAOKA MIYANODAI HAITSU #314 1-3-1 MIYANODAI SAKURA-SHI , CHIBA-KEN M0 285-0857
Business Address
Otsuka Masaya (Filed by) CIK: 0002027245 (see all company filings)

Type: SC 13G/A